News
From APA 
Rachel Johnston, Regional Director/ State Government Relations from the APA, provided us with the following headlines from Psychiatric News and an Advocacy update.
What to Expect in 2026 – Medicare Payment, Quality and Telehealth Policies
On Tuesday, December 2 from 12-12:30p ET, APA will provide a concise update on key Medicare policy changes affecting psychiatric practice that take effect January 1, 2026. This session will review finalized Medicare policies influenced by APA’s advocacy efforts, including updates on payment, coverage of services, and telehealth regulations. We’ll also provide the latest information on telehealth and teleprescribing of controlled substances. Please register for this webinar here
Rejoyn: First App Cleared by FDA for Depression; Cost, Efficacy Unclear
Linda M. Richmond
A new smartphone app promises to help treat people who don’t fully respond to their antidepressant. Whether insurance will cover it and whether apps that go through the FDA clearance process will ultimately reach patients remains unclear.
Calls to Poison Centers Involving Psilocybin Rising in Youth
Terri D’Arrigo
Decriminalization, legalization of psilocybin likely play roles in both increased exposure and poisoning.
_________________________________________________________________________________________________________________________________________
Fall 2025 Conference
We had a great conference this November!
Thank you to Deidre Yellowhair, PhD, Poone Haghani Tehrani, MD, and Robert Olsen, MD, for their exceptional presentations.
Newsletter
Events
Save the Date
PMANM Spring 2026 Conference
April 2026
Join PMANM
PMANM members receive the clinical updates needed to stay informed, the programs and patient care resources needed to deliver optimal care, and access to meetings, virtual events, and networking opportunities that helps to empower career advancement.









